Lv3
358 积分 2022-01-13 加入
Randomized optimal selection design for dose optimization
3个月前
已完结
Tumor Lysis Syndrome
3个月前
已完结
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma
4个月前
已关闭
Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study
4个月前
已关闭
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
4个月前
已关闭
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
4个月前
已完结
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
4个月前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
4个月前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
5个月前
已完结
Epigenetic Therapy in a Rare Ovarian Cancer — A Double-Edged Sword
5个月前
已完结
皖公网安备34019202002308
